We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-3.13%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$801B
AUM Growth
-$29.1B
Cap. Flow
+$16.3B
Cap. Flow %
2.03%
Top 10 Hldgs %
24.5%
Holding
5,100
New
137
Increased
3,082
Reduced
1,102
Closed
125

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.3B
2
MSFT icon
Microsoft
MSFT
+$1.3B
3
AMD icon
Advanced Micro Devices
AMD
+$925M
4
SPGI icon
S&P Global
SPGI
+$894M
5
TSLA icon
Tesla
TSLA
+$716M

Sector Composition

Rank Sector Weight
1 Technology 25.39%
2 Financials 13.32%
3 Healthcare 13.3%
4 Consumer Discretionary 11.44%
5 Communication Services 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQX icon
3826
Equinox Gold
EQX
$7.56B
$631K ﹤0.01%
76,510
DYAI icon
3827
Dyadic International
DYAI
$39.4M
$630K ﹤0.01%
209,303
-124
-0.1% -$465
MACK
3828
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$630K ﹤0.01%
99,662
+2,970
+3% +$16.7K
SMMT icon
3829
Summit Therapeutics
SMMT
$11B
$629K ﹤0.01%
257,056
+8,235
+3% +$20.8K
HAAC
3830
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$629K ﹤0.01%
63,913
MAXN
3831
DELISTED
Maxeon Solar Technologies
MAXN
$627K ﹤0.01%
433
+2
+0.5% +$2.3K
ASTL icon
3832
Algoma Steel
ASTL
$445M
$626K ﹤0.01%
55,671
AGPU
3833
Axe Compute Inc
AGPU
$103M
$626K ﹤0.01%
2,137
+76
+4% +$20.2K
GHM icon
3834
Graham Corp
GHM
$1.23B
$625K ﹤0.01%
81,133
+772
+1% +$7.63K
QRHC icon
3835
Quest Resource Holding
QRHC
$26.1M
$622K ﹤0.01%
101,256
+2,112
+2% +$13.9K
ZDGE icon
3836
Zedge
ZDGE
$38.9M
$621K ﹤0.01%
102,104
-31,865
-24% -$225K
FTCH
3837
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$621K ﹤0.01%
41,087
+2,242
+6% +$43.4K
CZWI icon
3838
Citizens Community Bancorp
CZWI
$211M
$620K ﹤0.01%
41,046
+1,832
+5% +$27.5K
CULP icon
3839
Culp Inc
CULP
$43.7M
$618K ﹤0.01%
77,856
-509
-0.6% -$4.33K
PROV icon
3840
Provident Financial
PROV
$112M
$617K ﹤0.01%
37,317
-936
-2% -$15.6K
MCHX icon
3841
Marchex
MCHX
$83.3M
$616K ﹤0.01%
269,343
-331
-0.1% -$744
CELU icon
3842
Celularity
CELU
$20.4M
$614K ﹤0.01%
7,051
LILM
3843
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$614K ﹤0.01%
154,385
-47,915
-24% -$221K
ITRN icon
3844
Ituran Location and Control
ITRN
$1.12B
$608K ﹤0.01%
26,426
-482
-2% -$11.2K
APLT
3845
DELISTED
Applied Therapeutics
APLT
$607K ﹤0.01%
287,930
-15,313
-5% -$41K
CAN
3846
Canaan Creative
CAN
$149M
$607K ﹤0.01%
111,943
LTBR icon
3847
Lightbridge
LTBR
$293M
$607K ﹤0.01%
72,719
+13,144
+22% +$99.2K
RDY icon
3848
Dr. Reddy's Laboratories
RDY
$10.1B
$606K ﹤0.01%
56,950
-27,340
-32% -$310K
FFBW
3849
DELISTED
FFBW, Inc. Common Stock
FFBW
$606K ﹤0.01%
50,170
+1,542
+3% +$18.5K
ACAH
3850
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$605K ﹤0.01%
61,965
+770
+1% +$7.54K

Similar funds

Geode Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Geode Capital Management's Q1 2022 filing shows 137 new, 3,082 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
  • Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
  • Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
  • Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
  • Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
  • Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
  • Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.

Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.